490 related articles for article (PubMed ID: 34223401)
21. Trends in COVID-19 Vaccine Administration and Effectiveness Through October 2021.
Winkelman TNA; Rai NK; Bodurtha PJ; Chamberlain AM; DeSilva M; Jeruzal J; Johnson SG; Kharbanda A; Klyn N; Mink PJ; Muscoplat M; Waring S; Yu Y; Drawz PE
JAMA Netw Open; 2022 Mar; 5(3):e225018. PubMed ID: 35357452
[TBL] [Abstract][Full Text] [Related]
22. Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study.
Kildegaard H; Lund LC; Højlund M; Stensballe LG; Pottegård A
BMJ; 2022 Apr; 377():e068898. PubMed ID: 35410884
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.
Ogilvie RP; Layton JB; Lloyd PC; Jiao Y; Djibo DA; Wong HL; Gruber JF; Parambi R; Deng J; Miller M; Song J; Weatherby LB; Peetluk L; Lo AC; Matuska K; Wernecke M; Bui CL; Clarke TC; Cho S; Bell EJ; Yang G; Amend KL; Forshee RA; Anderson SA; McMahill-Walraven CN; Chillarige Y; Anthony MS; Seeger JD; Shoaibi A
BMC Pediatr; 2024 Apr; 24(1):276. PubMed ID: 38671379
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M; Puopolo M; Morciano C; Spuri M; Spila Alegiani S; Filia A; D'Ancona F; Del Manso M; Riccardo F; Tallon M; Proietti V; Sacco C; Massari M; Da Cas R; Mateo-Urdiales A; Siddu A; Battilomo S; Bella A; Palamara AT; Popoli P; Brusaferro S; Rezza G; Menniti Ippolito F; Pezzotti P;
BMJ; 2022 Feb; 376():e069052. PubMed ID: 35144968
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19.
Corchado-Garcia J; Zemmour D; Hughes T; Bandi H; Cristea-Platon T; Lenehan P; Pawlowski C; Bade S; O'Horo JC; Gores GJ; Williams AW; Badley AD; Halamka J; Virk A; Swift MD; Wagner T; Soundararajan V
JAMA Netw Open; 2021 Nov; 4(11):e2132540. PubMed ID: 34726743
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
Lopez Bernal J; Andrews N; Gower C; Robertson C; Stowe J; Tessier E; Simmons R; Cottrell S; Roberts R; O'Doherty M; Brown K; Cameron C; Stockton D; McMenamin J; Ramsay M
BMJ; 2021 May; 373():n1088. PubMed ID: 33985964
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel.
Pilishvili T; Gierke R; Fleming-Dutra KE; Farrar JL; Mohr NM; Talan DA; Krishnadasan A; Harland KK; Smithline HA; Hou PC; Lee LC; Lim SC; Moran GJ; Krebs E; Steele MT; Beiser DG; Faine B; Haran JP; Nandi U; Schrading WA; Chinnock B; Henning DJ; Lovecchio F; Lee J; Barter D; Brackney M; Fridkin SK; Marceaux-Galli K; Lim S; Phipps EC; Dumyati G; Pierce R; Markus TM; Anderson DJ; Debes AK; Lin MY; Mayer J; Kwon JH; Safdar N; Fischer M; Singleton R; Chea N; Magill SS; Verani JR; Schrag SJ;
N Engl J Med; 2021 Dec; 385(25):e90. PubMed ID: 34551224
[TBL] [Abstract][Full Text] [Related]
29. Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection.
Puranik A; Lenehan PJ; Silvert E; Niesen MJM; Corchado-Garcia J; O'Horo JC; Virk A; Swift MD; Gordon JE; Speicher LL; Geyer HL; Kremers W; Halamka J; Badley AD; Venkatakrishnan AJ; Soundararajan V
Med; 2022 Jan; 3(1):28-41.e8. PubMed ID: 34927113
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of mRNA-1273 and BNT162b2 COVID-19 vaccines in immunocompromised individuals: a systematic review and meta-analysis using the GRADE framework.
Wang X; Haeussler K; Spellman A; Phillips LE; Ramiller A; Bausch-Jurken MT; Sharma P; Krivelyova A; Vats S; Van de Velde N
Front Immunol; 2023; 14():1204831. PubMed ID: 37771594
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of COVID-19 vaccines in patients taking immunosuppressants.
Shen C; Risk M; Schiopu E; Hayek SS; Xie T; Holevinski L; Akin C; Freed G; Zhao L
Ann Rheum Dis; 2022 Jun; 81(6):875-880. PubMed ID: 35197265
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
[TBL] [Abstract][Full Text] [Related]
33. Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population.
Butt AA; Talisa VB; Yan P; Shaikh OS; Omer SB; Mayr FB
Clin Infect Dis; 2022 Aug; 75(1):e579-e584. PubMed ID: 35245940
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study.
Chin ET; Leidner D; Zhang Y; Long E; Prince L; Schrag SJ; Verani JR; Wiegand RE; Alarid-Escudero F; Goldhaber-Fiebert JD; Studdert DM; Andrews JR; Salomon JA
Clin Infect Dis; 2022 Aug; 75(1):e838-e845. PubMed ID: 35083482
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021.
Zambrano LD; Newhams MM; Olson SM; Halasa NB; Price AM; Boom JA; Sahni LC; Kamidani S; Tarquinio KM; Maddux AB; Heidemann SM; Bhumbra SS; Bline KE; Nofziger RA; Hobbs CV; Bradford TT; Cvijanovich NZ; Irby K; Mack EH; Cullimore ML; Pannaraj PS; Kong M; Walker TC; Gertz SJ; Michelson KN; Cameron MA; Chiotos K; Maamari M; Schuster JE; Orzel AO; Patel MM; Campbell AP; Randolph AG;
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):52-58. PubMed ID: 35025852
[TBL] [Abstract][Full Text] [Related]
36. Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.
Mues KE; Kirk B; Patel DA; Gelman A; Chavers LS; Talarico CA; Esposito DB; Martin D; Mansi J; Chen X; Gatto NM; Van de Velde N
Vaccine; 2022 Nov; 40(47):6730-6739. PubMed ID: 36163093
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents.
Olson SM; Newhams MM; Halasa NB; Price AM; Boom JA; Sahni LC; Pannaraj PS; Irby K; Walker TC; Schwartz SP; Maddux AB; Mack EH; Bradford TT; Schuster JE; Nofziger RA; Cameron MA; Chiotos K; Cullimore ML; Gertz SJ; Levy ER; Kong M; Cvijanovich NZ; Staat MA; Kamidani S; Chatani BM; Bhumbra SS; Bline KE; Gaspers MG; Hobbs CV; Heidemann SM; Maamari M; Flori HR; Hume JR; Zinter MS; Michelson KN; Zambrano LD; Campbell AP; Patel MM; Randolph AG;
N Engl J Med; 2022 Feb; 386(8):713-723. PubMed ID: 35021004
[TBL] [Abstract][Full Text] [Related]
38. Iron deficiency and the effectiveness of the BNT162b2 vaccine for SARS-CoV-2 infection: A retrospective, longitudinal analysis of real-world data.
Tene L; Karasik A; Chodick G; Pereira DIA; Schou H; Waechter S; Göhring UM; Drakesmith H
PLoS One; 2023; 18(5):e0285606. PubMed ID: 37216375
[TBL] [Abstract][Full Text] [Related]
39. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
40. Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.
Brunner-Ziegler S; Spath T; Kornek G; König F; Parschalk B; Schnetzinger M; Straßl RP; Savic R; Foit A; Resch H; Thalhammer F
Clin Microbiol Infect; 2022 Apr; 28(4):596-601. PubMed ID: 34915073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
